Theravance Biopharma Stock
Your prediction
Theravance Biopharma Stock
A loss of -1.190% shows a downward development for Theravance Biopharma.
Pros and Cons of Theravance Biopharma in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Theravance Biopharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -1.190% | 3.205% | 8.054% | 90.533% | 2.548% | 65.979% | 19.259% |
| Rockwell Medical Inc. | -0.650% | -5.576% | -1.316% | -60.860% | 16.408% | -46.062% | -92.089% |
| Pacira Pharmaceuticals | -0.510% | -7.477% | -7.477% | 11.864% | -8.333% | -41.071% | -65.565% |
| Twist Bioscience Corp | 5.060% | 11.475% | 23.824% | -25.377% | 17.199% | 33.224% | -75.642% |
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue